Literature DB >> 17342749

Reactive oxygen species mediate androgen receptor- and serum starvation-elicited downstream signaling of ADAM9 expression in human prostate cancer cells.

Katsumi Shigemura1, Shian-Ying Sung, Hiroyuki Kubo, Rebecca S Arnold, Masato Fujisawa, Akinobu Gotoh, Haiyen E Zhau, Leland W K Chung.   

Abstract

BACKGROUND: The A Disintegrin And Metalloprotease (ADAM) family is a group of transmembrane proteins containing cell adhesive and proteolytic functional domains. ADAM9 expression was shown to be mediated by androgen receptor (AR) and stress conditions. This study determined a common mediator responsible for ADAM9 protein regulation which supports human prostate cancer (PCa) cell growth and survival.
METHODS: ADAM9 protein expression was measured under androgen, anti-androgen, hydrogen peroxide, and/or serum starvation conditions in PCa cells. The roles of reactive oxygen species (ROS) were assessed in the presence or absence of recombinant catalase, or in cells stably transfected with either catalase- or a control neo-cDNA expression vector. ROS was assayed by dihydroethidium (DHE) followed by FACS analysis.
RESULTS: ADAM9 protein expression was upregulated by androgen in AR-positive but not in AR-negative PCa cells. The anti-androgen bicalutamide effectively blocked this induction. While serum starvation enhanced ADAM9 expression in AR-positive PCa cells, this stress condition did not alter ADAM9 expression in AR-negative PCa cells. Parallel results also showed that androgen treatment or serum starvation enhanced ROS only in AR-positive but not in AR-negative PCa cells. ROS appears to be a common downstream mediator of androgen- or serum starvation-induced ADAM9 expression since addition of hydrogen peroxide or introduction of catalase, either enhanced or abolished respectively ADAM9 protein expression by both AR-positive and -negative PCa cells.
CONCLUSIONS: These findings suggest that ROS is: a common mediator responsible for ADAM9 protein induction in human PCa cells, downstream from AR, and stress response signaling. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17342749     DOI: 10.1002/pros.20565

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  25 in total

1.  Secreted and membrane-bound isoforms of protease ADAM9 have opposing effects on breast cancer cell migration.

Authors:  Jessica L Fry; Alex Toker
Journal:  Cancer Res       Date:  2010-08-24       Impact factor: 12.701

2.  Inhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapy.

Authors:  Sajni Josson; Cynthia S Anderson; Shian-Ying Sung; Peter A S Johnstone; Hiroyuki Kubo; Chia-Ling Hsieh; Rebecca Arnold; Murali Gururajan; Clayton Yates; Leland W K Chung
Journal:  Prostate       Date:  2011-02-15       Impact factor: 4.104

3.  The effect of disintegrin-metalloproteinase ADAM9 in gastric cancer progression.

Authors:  Jeong Min Kim; Hei-Cheul Jeung; Sun Young Rha; Eun Jeong Yu; Tae Soo Kim; You Keun Shin; Xianglan Zhang; Kyu Hyun Park; Seung Woo Park; Hyun Cheol Chung; Garth Powis
Journal:  Mol Cancer Ther       Date:  2014-10-24       Impact factor: 6.261

Review 4.  Oxidative stress in prostate cancer.

Authors:  Lakshmipathi Khandrika; Binod Kumar; Sweaty Koul; Paul Maroni; Hari K Koul
Journal:  Cancer Lett       Date:  2009-01-30       Impact factor: 8.679

5.  Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis.

Authors:  Shian-Ying Sung; Chia-Ling Hsieh; Andrew Law; Haiyen E Zhau; Sen Pathak; Asha S Multani; Sharon Lim; Ilsa M Coleman; Li-Chin Wu; William D Figg; William L Dahut; Peter Nelson; Jae K Lee; Mahul B Amin; Robert Lyles; Peter A J Johnstone; Fray F Marshall; Leland W K Chung
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

6.  ADAM9 is involved in pathological retinal neovascularization.

Authors:  Victor Guaiquil; Steven Swendeman; Tsunehiko Yoshida; Sai Chavala; Peter A Campochiaro; Carl P Blobel
Journal:  Mol Cell Biol       Date:  2009-03-09       Impact factor: 4.272

7.  Combined Dynamic Alterations in Urinary VEGF Levels and Tissue ADAM9 Expression as Markers for Lethal Phenotypic Progression of Prostate Cancer.

Authors:  Chen-Chin Pen; Che-Ming Liu; Cho-Chin Lin; Chia-Chen Lin; Teng-Fu Hsieh; Sajni Josson; Yun-Chi He; Leland W K Chung; Keh-Liang Lin; Shian-Ying Sung
Journal:  Chin J Physiol       Date:  2012-12-31       Impact factor: 1.764

8.  Shedding of collagen XVII/BP180 in skin depends on both ADAM10 and ADAM9.

Authors:  Claus-Werner Franzke; Leena Bruckner-Tuderman; Carl P Blobel
Journal:  J Biol Chem       Date:  2009-07-01       Impact factor: 5.157

9.  Common and distinct mechanisms of different redox-active carcinogens involved in the transformation of mouse JB6P+ cells.

Authors:  Sun Yang; Bobbye Misner; Rita Chiu; Frank L Meyskens
Journal:  Mol Carcinog       Date:  2008-07       Impact factor: 4.784

Review 10.  The role of protease activity in ErbB biology.

Authors:  Carl P Blobel; Graham Carpenter; Matthew Freeman
Journal:  Exp Cell Res       Date:  2008-10-25       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.